Cargando…
A novel nanomicelle composed from PEGylated TB di-peptide could be successfully used as a BCG booster
OBJECTIVE(S): Tuberculosis affects one-third of the world’s population and leads to a high rate of morbidity and mortality. Bacillus Chalmette–Guerin (BCG) as the only approved vaccine for the Mycobacterium tuberculosis (Mtb) does not show enough protection in the vaccinated population. MATERIALS AN...
Autores principales: | Firouzi, Zohreh, Jaafari, Mahmoud Reza, Sankian, Mojtaba, Zare, Sirwan, Tafaghodi, Mohsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124544/ https://www.ncbi.nlm.nih.gov/pubmed/35655599 http://dx.doi.org/10.22038/IJBMS.2022.61373.13583 |
Ejemplares similares
-
Mucosal and systemic immunization against tuberculosis by ISCOMATRIX nano adjuvant co-administered with alginate coated chitosan nanoparticles
por: Najafi, Adel, et al.
Publicado: (2023) -
Cloning, Expression, and Refolding of PPE17 Protein of Mycobacterium Tuberculosis as a Promising Vaccine Candidate
por: Najafi, Adel, et al.
Publicado: (2019) -
Age-related waning of immune responses to BCG in healthy children supports the need for a booster dose of BCG in TB endemic countries
por: Whittaker, Elizabeth, et al.
Publicado: (2018) -
Novel nanomicelle formulation to enhance bioavailability and stability of curcuminoids
por: Hatamipour, Mahdi, et al.
Publicado: (2019) -
New Oral Formulation and in Vitro Evaluation of Docetaxel-Loaded Nanomicelles
por: Hekmat, Atefeh, et al.
Publicado: (2016)